DRC Ebola outbreak spreads to border regions as contact tracing falls critically short

7,890 confirmed cases and 3,799 deaths reported as of September 23, with nearly half of infected persons dying; population displacement complicating outbreak response.
When the outbreak is at community level, we cannot talk about control.
Dr. Jean Kaseya of the Africa CDC on the failure of contact tracing to keep pace with transmission.
Mark

So the virus has now reached border regions. Does that mean it's about to spread to neighboring countries?

Mimi

It's already in areas adjacent to the Central African Republic and South Sudan, which creates that risk. But what's more immediately pressing is that the outbreak is still accelerating within the DRC itself—the contact tracing is so far behind that the virus is spreading faster than they can track it.

Luke

How confident are we in those case numbers? Are they confirmed lab results or estimates?

Mimi

The 7,890 are confirmed cases as of September 23, according to WHO data. That's a solid figure. The real problem is the contacts—Kaseya says there should be 420,000 based on epidemiological models, but they've only identified 30,000.

Mark

Why is contact tracing falling so short? Is it a staffing problem, a logistics problem, or something else?

Mimi

It's multiple things. Conflict is blocking access to some areas. Displacement means people are scattered and harder to locate. And patients themselves are avoiding hospitals because they believe going there means they'll die—so cases aren't being identified in the first place.

Luke

That last point is crucial. If patients aren't presenting to health facilities, then the 7,890 confirmed cases might be a significant undercount of actual infections.

Mimi

Exactly. The cases we know about are likely just the visible portion. The real number of infected people is probably much higher.

Mark

What about the vaccine situation? I thought there were Ebola vaccines.

Mimi

There are vaccines for the Zaire strain, which caused previous outbreaks in the DRC. But this is Bundibugyo, and there's no approved vaccine for it yet. That's why the WHO is running accelerated trials.

Luke

So they're essentially learning about this strain in real time while trying to stop an outbreak. That's a significant constraint.

Mark

How does the mortality rate compare to previous Ebola outbreaks?

Mimi

The overall rate here is nearly fifty percent. In North Kivu specifically, it's almost sixty percent—higher than the national average. The 2018-2020 Zaire outbreak had a mortality rate around fifty percent as well, so this is tracking similarly severe.

Luke

But we should note that mortality rates can be misleading if case identification is incomplete. If milder cases aren't being detected, the confirmed cases skew toward more severe infections, which artificially raises the mortality rate.

  • The virus has breached border regions near the Central African Republic and South Sudan, raising the alarm that a regional catastrophe could become an international one.
  • Contact tracing — the essential thread of outbreak control — has collapsed to a fraction of what is needed: only 30,000 of an estimated 420,000 exposed contacts have been identified or monitored.
  • Armed conflict and mass displacement are physically blocking health workers from reaching affected communities, allowing the virus to travel faster than any response can follow.
  • In North Kivu, where nearly 60% of diagnosed patients have died, people are avoiding hospitals out of fear that seeking care is a death sentence — arriving only when survival is already unlikely.
  • With no approved vaccine and a virus that mimics malaria and typhoid in its early stages, the WHO is racing to accelerate clinical trials while the outbreak continues to accelerate around them.

In the Democratic Republic of the Congo, a disease without an approved vaccine is moving through a land fractured by conflict, crossing into border regions and exposing the fragility of systems meant to protect the most vulnerable. The Bundibugyo strain of Ebola has now touched 63 health zones across seven provinces, claiming nearly half of the nearly 8,000 lives it has reached since May. What unfolds here is not merely an outbreak but a reckoning with the limits of public health when fear, war, and diagnostic uncertainty conspire against intervention.

The Ebola outbreak in the Democratic Republic of the Congo has entered a dangerous new phase, with the Bundibugyo strain confirmed in border regions near the Central African Republic and South Sudan. Sixty-three health zones across seven provinces are now affected. As of late September, nearly 7,900 infections and 3,800 deaths have been recorded — a mortality rate approaching fifty percent.

Ituri province in the northeast remains the epicenter, accounting for more than 6,000 cases since the outbreak began in May. North Kivu has emerged as a particular concern: nearly sixty percent of patients diagnosed there have died, and the province reported over 560 new cases in just three weeks. It has faced Ebola before, but the Bundibugyo strain presents unfamiliar challenges — chief among them, the absence of any approved vaccine.

The virus's early symptoms closely resemble malaria or typhoid, allowing it to spread before it is recognized. But the most critical failure may be in contact tracing. Of the estimated 420,000 people who should have been identified and monitored given the case count, only 30,000 have been located — a shortfall of nearly ninety percent. Africa CDC Director-General Dr. Jean Kaseya put it plainly: at community transmission levels, control is not yet possible.

Conflict and displacement are compounding every weakness in the response. Armed groups have made entire areas inaccessible to health workers, while displaced populations have scattered across borders where surveillance is minimal. In Butembo, a local physician described a community belief that going to a hospital means being sent to a treatment center to die — a fear that is keeping patients away until their illness is beyond intervention.

The coming weeks will be decisive. Whether contact tracing can be scaled, whether experimental vaccines prove effective, and whether conflict eases enough to allow access will determine whether this outbreak remains a regional tragedy or grows into something far harder to contain.

The Ebola outbreak spreading across the Democratic Republic of the Congo has crossed into border regions, marking a dangerous expansion of a crisis already straining the country's health infrastructure to its breaking point. The Bundibugyo strain, confirmed in new cases in Bulu near the Central African Republic and Dungu near South Sudan, has now reached 63 health zones across seven provinces. As of mid-September, the DRC had documented 7,890 confirmed infections and 3,799 deaths—a mortality rate approaching fifty percent.

Ituri province in the northeast remains the outbreak's epicenter, accounting for more than 6,000 of those cases since the epidemic began in May. North Kivu, the second-hardest-hit province, has become a particular concern: nearly sixty percent of patients diagnosed there have died, well above the national average. In the past three weeks alone, North Kivu reported 567 new confirmed cases, representing roughly a third of all new infections and deaths across the country. The province has weathered Ebola before—three previous outbreaks, including a devastating 2018-to-2020 surge caused by the Zaire strain—but this iteration of the virus presents unfamiliar challenges.

The Bundibugyo strain has no approved vaccine, a critical vulnerability that has prompted the WHO to accelerate clinical trials of potential treatments. Early in infection, the virus produces symptoms easily confused with malaria or typhoid fever, allowing it to spread before patients and health workers recognize what they are facing. This diagnostic ambiguity, combined with the virus's novelty, has left responders operating with incomplete knowledge of how to contain it.

Yet the outbreak's most immediate threat may not be the virus itself but the failure of contact tracing—the foundational tool for stopping transmission. According to Dr. Jean Kaseya, director-general of the Africa Centres for Disease Control and Prevention, the more than 7,000 confirmed cases should have generated approximately 420,000 identified contacts. Instead, health workers have managed to locate and monitor just 30,000 people. That gap—a shortfall of nearly ninety percent—means the vast majority of those exposed to the virus are moving through communities unmonitored and potentially infectious. "When the outbreak is at community level, we cannot talk about control," Kaseya said, naming the reality plainly.

Conflict and displacement are eroding the response from multiple angles. WHO Director-General Tedros Adhanom Ghebreyesus noted that armed conflict has made it nearly impossible for health workers to reach affected populations in some areas, while mass displacement has scattered people across borders and into regions where surveillance is minimal. The combination has created conditions where the virus can move faster than the response can follow.

Another barrier is fear. Patients in North Kivu are avoiding hospitals, waiting until infection has progressed to its most severe and least treatable stages. Dr. Michel Paluku Mukuloli, who works at a hospital in Butembo, described the belief circulating in his community: that arriving at a health facility means immediate transfer to a treatment center to die. That perception, whether rooted in past experience or rumor, is now shaping behavior in ways that make early intervention impossible and drive up mortality. By the time patients present themselves, treatment options have narrowed and survival becomes unlikely.

The outbreak continues to accelerate in the provinces where it took root earliest, and its expansion into border zones raises the prospect of international spread. The health system's inability to trace contacts, the absence of approved vaccines, the virus's capacity to masquerade as common illnesses, and the population's reluctance to seek care have converged into a crisis that appears to be outpacing containment efforts. What happens in the coming weeks—whether contact tracing can be scaled, whether vaccines prove effective, whether conflict subsides enough to allow health workers access—will determine whether this outbreak remains a regional catastrophe or becomes something far larger.

It's very difficult to see Ebola in isolation because even our response to Ebola is affected by the conflict, because there is displacement and there is an access problem to some areas.
— WHO Director-General Tedros Adhanom Ghebreyesus
Patients think that if they arrive at the hospital, they will be immediately sent to the treatment centre to die.
— Dr. Michel Paluku Mukuloli, hospital worker in North Kivu's Butembo
Quer a matéria completa? Leia o original em Al Jazeera ↗
Fale Conosco FAQ